Clinical trial Recruiting at 1 site Observational Ages 18 and up

Alert frequency and nurse/patient satisfaction with a wireless continuous vital-sign monitoring app

Official title: Alert Frequency, Nurse, and Patient Satisfaction With a Continuous Wireless Vital Sign Monitoring Software Across Health Care Systems and Cultures

Run by University Hospital Bispebjerg and Frederiksberg · NCT06289699 · Data updated 2026-11-12

This pilot will test whether a wearable continuous vital-sign monitoring system and its app work well and are acceptable to adult patients and nurses on general wards after surgery or acute medical admission.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment100 (estimated)
SponsorUniversity Hospital Bispebjerg and Frederiksberg
Academic / other
Locations5 sites (Cleveland, Ohio and 4 other locations)
StatusRecruiting
StartedFebruary 26, 2024
Main results expectedAugust 1, 2026
Study endsDecember 31, 2026
Registry record updatedAugust 12, 2025
Trial IDNCT06289699 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18) expected to stay ≥2 days who are admitted for surgery lasting >2 hours or admitted for an acute medical condition with specified abnormal vital signs within 24 hours of admission are ideal candidates.

Probably not a fit

Patients with pacemakers or ICDs, those allergic to plaster or silicone, those unable to give informed consent, or those expected not to cooperate are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective international multi-centre pilot that enrolls about 20 patients and 20 nurses per centre to use a wireless continuous vital-sign monitoring system alongside standard monitoring. Patients are monitored for four days postoperatively or for four days after acute admission and until discharge, and nurses take responsibility for monitored patients for a full shift. The study compares alerts generated in the mobile/web app with alerts that should have been triggered based on measured data, uses questionnaires to measure nurse and patient satisfaction, and conducts semi-structured interviews to map differences in monitoring practices across health-care systems and cultures. Devices used are validated FDA or CE-approved systems (e.g., Sotera Visimobile or Isansys Lifeguard) paired with the CE-approved WARD app.

Why it matters

Potential benefit: If successful, this could reduce missed signs of deterioration and make monitoring less intrusive and easier to use for patients and nurses.

How similar studies have gone: Other studies of wireless continuous vital-sign monitoring have shown feasibility and improved detection in some settings, but findings on alert burden and clinical outcome benefits have been mixed.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults (≥18 years)
* Expected stay in the hospital ≥2 days
* Admitted for surgery with expected duration of surgery \>2 hours or admitted for acute medical condition with at least one of the following vital sign deviations within 24 hours of acute admission, recorded by the staff

  * RR \> 21 breaths pr minute
  * RR \< 11 breaths pr minute
  * Pulse (P) \> 91 beats pr minute
  * Pulse (P) \< 50 beats pr minute
  * SpO2 \< 94 % without oxygen supplementation
  * Systolic BP \< 110 mmHg
  * Systolic BP \> 220 mmHg

Exclusion Criteria:

* Participant expected not to cooperate with study procedures.
* Allergy to plaster or silicone.
* Pacemaker or Implantable Cardioverter Defibrillator (ICD) device.
* Inability to give informed consent.

Where it's running

  • University Medical Center Groningen, Department of Anesthesiology
    Groningen, Netherlands
    Recruiting
  • The Cleveland Clinic Foundation, General Anesthesiology
    Cleveland, Ohio, United States
    Not yet recruiting
  • Universitätsklinikum Hamburg-Eppendorf (UKE), Zentrum für Anästhesiologie und Intensivmedizin, Klinik und Poliklinik für Anästhesiologie
    Hamburg, Germany
    Completed
  • St. Olavs Hospital HF, Klinikk for anestesi og intensivmedisin
    Trondheim, Norway
    Completed
  • Liverpool University Hospitals NHS Foundation Trust
    Liverpool, United Kingdom
    Not yet recruiting

Study contacts

  • Principal investigator: Christian S Meyhoff, MD, PhD — Copenhagen University Hospital - Bispebjerg and Frederiksberg, Copenhagen, Denmark
  • Study coordinator: Katja K Head of Clinical, MD
  • Email: katja.groenbaek@ward247.com
  • Phone: 004528781188

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.